<?xml version="1.0"?>
<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20190208//EN"
       "JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="1.4" xml:lang="en">
 <front>
  <journal-meta>
   <journal-id journal-id-type="publisher-id">Tavricheskiy Mediko-Biologicheskiy Vestnik</journal-id>
   <journal-title-group>
    <journal-title xml:lang="en">Tavricheskiy Mediko-Biologicheskiy Vestnik</journal-title>
    <trans-title-group xml:lang="ru">
     <trans-title>Таврический медико-биологический вестник</trans-title>
    </trans-title-group>
   </journal-title-group>
   <issn publication-format="print">2070-8092</issn>
  </journal-meta>
  <article-meta>
   <article-id pub-id-type="publisher-id">54715</article-id>
   <article-id pub-id-type="doi">10.29039/2070-8092-2020-23-4-91-97</article-id>
   <article-categories>
    <subj-group subj-group-type="toc-heading" xml:lang="ru">
     <subject>Оригинальные статьи</subject>
    </subj-group>
    <subj-group subj-group-type="toc-heading" xml:lang="en">
     <subject>Original articles</subject>
    </subj-group>
    <subj-group>
     <subject>Оригинальные статьи</subject>
    </subj-group>
   </article-categories>
   <title-group>
    <article-title xml:lang="en">TYPE 1 DIABETES MELLITUS IN PEDIATRIC PRACTICE AND DAMAGE TO THE CENTRAL NERVOUS SYSTEM</article-title>
    <trans-title-group xml:lang="ru">
     <trans-title>САХАРНЫЙ ДИАБЕТ I ТИПА В ПЕДИАТРИЧЕСКОЙ ПРАКТИКЕ И ПОРАЖЕНИЯ ЦЕНТРАЛЬНОЙ НЕРВНОЙ СИСТЕМЫ</trans-title>
    </trans-title-group>
   </title-group>
   <contrib-group content-type="authors">
    <contrib contrib-type="author">
     <name-alternatives>
      <name xml:lang="ru">
       <surname>Быков</surname>
       <given-names>Ю. В.</given-names>
      </name>
      <name xml:lang="en">
       <surname>Bykov</surname>
       <given-names>Yu. V.</given-names>
      </name>
     </name-alternatives>
     <xref ref-type="aff" rid="aff-1"/>
    </contrib>
   </contrib-group>
   <aff-alternatives id="aff-1">
    <aff>
     <institution xml:lang="ru">Ставропольский государственный медицинский университет</institution>
    </aff>
    <aff>
     <institution xml:lang="en">Stavropol State Medical University</institution>
    </aff>
   </aff-alternatives>
   <pub-date publication-format="print" date-type="pub" iso-8601-date="2022-10-21T11:49:11+03:00">
    <day>21</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <pub-date publication-format="electronic" date-type="pub" iso-8601-date="2022-10-21T11:49:11+03:00">
    <day>21</day>
    <month>10</month>
    <year>2022</year>
   </pub-date>
   <volume>23</volume>
   <issue>4</issue>
   <fpage>91</fpage>
   <lpage>97</lpage>
   <history>
    <date date-type="received" iso-8601-date="2022-10-21T00:00:00+03:00">
     <day>21</day>
     <month>10</month>
     <year>2022</year>
    </date>
   </history>
   <self-uri xlink:href="https://ma.cfuv.ru/site/page/show/docid/260997">https://ma.cfuv.ru/site/page/show/docid/260997</self-uri>
   <abstract xml:lang="ru">
    <p>Анкилозирующий спондилит вызывает морфологическое или функциональное поражение сердечно-сосудистой системы в 22% случаях. Применение современных методов исследования функции сердца, таких как холтеровское мониторирование ЭКГ, позволяется выявлять нарушения ритма и проводимости, синдром удлиненного интервала QT. Изменение параметров интервала QT, таких как его продолжительность и дисперсия, можно рассматривать как предиктор развития кардиоваскулярных катастроф, фатальных аритмий. В статье проведен анализ величин QT/RR и QTc при проведении Холтеровского мониторирования ЭКГ у 92 пациентов с диагнозом Анкилозирующий спондилит в зависимости от стадии заболевания, активности патологического процесса, серопозитивности по HLA B27. Установлено достоверное увеличение QT/RR и QTс за активный и пассивный периоды проведения Холтеровского мониторирования ЭКГ в сравнении с группой контроля. У пациентов с анкилозирующим спондилитом выявлены желудочковые нарушения ритма, которые взаимосвязаны с удлинением интервала QT. Стандартизированное проведение у больных с АС Холтеровского мониторирования ЭКГ, с учетом суточной дисперсии интервала QT может стать универсальным, малоинвазивным и низкозатратным методом оценки риска развития кардиоваскулярных нарушений у пациентов с Анкилозирующим спондилитом.</p>
   </abstract>
   <trans-abstract xml:lang="en">
    <p>Diabetes mellitus (DM) is one of severe and progressive endocrine system diseases that occur in childhood. Type 1 DM, the form most commonly seen in children and adolescents, develops as an autoimmune process that gradually inflicts damage and causes death of pancreatic β cells. During its course MD gives rise to a number of severe complications, the most significant of which is the dysfunction and damage of the central nervous system (CNS). The leading causes of CNS damage in DM can be subdivided into vascular, metabolic, neurodegenerative and inflammatory. The main clinical presentation of DM in pediatric practice is cognitive impairment, characterized by a decline in memory and intellectual function. Despite the success that have been achieved in the MD treatment field, prevention and detection of CNS function impairment occurring in this disease remains an important direction for research in the endocrine practice, especially when treating children and adolescents.</p>
   </trans-abstract>
   <kwd-group xml:lang="ru">
    <kwd>анкилозирующий спондилит</kwd>
    <kwd>интервал QT</kwd>
    <kwd>Холтеровское мониторирование  ЭКГ</kwd>
   </kwd-group>
   <kwd-group xml:lang="en">
    <kwd>diabetes mellitus</kwd>
    <kwd>central nervous system dysfunction</kwd>
    <kwd>cognitive impairment</kwd>
    <kwd>prevention</kwd>
    <kwd>children and adolescents</kwd>
   </kwd-group>
  </article-meta>
 </front>
 <body>
  <p></p>
 </body>
 <back>
  <ref-list>
   <ref id="B1">
    <label>1.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Arroyave F., Montaсo D., Lizcano F. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy  with  Induced  Pluripotent  Stem  Cells. 2020;21(22):8685. doi: 10.3390/ijms21228685.</mixed-citation>
     <mixed-citation xml:lang="en">Arroyave F., Montaso D., Lizcano F. Diabetes Mellitus Is a Chronic Disease that Can Benefit from Therapy  with  Induced  Pluripotent  Stem  Cells. 2020;21(22):8685. doi: 10.3390/ijms21228685.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B2">
    <label>2.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Avilйs-Santa M.L., Monroig-Rivera A., Soto- Soto A.,  Lindberg N.M. Current State of Diabetes Mellitus  Prevalence,  Awareness,  Treatment,  and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across theContinent.CurrDiab Rep. 2020;20(11):62. doi:10.1007/ s11892-020-01341-9.</mixed-citation>
     <mixed-citation xml:lang="en">Avilys-Santa M.L., Monroig-Rivera A., Soto- Soto A.,  Lindberg N.M. Current State of Diabetes Mellitus  Prevalence,  Awareness,  Treatment,  and Control in Latin America: Challenges and Innovative Solutions to Improve Health Outcomes Across theContinent.CurrDiab Rep. 2020;20(11):62. doi:10.1007/ s11892-020-01341-9.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B3">
    <label>3.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Zhao R.,  Lu Z., Yang J., Zhang L.,  Li Y., Zhang X. Drug Delivery System in the Treatment of Diabetes Mellitus.  Front  BioengBiotechnol.  2020;8:880.  doi: 10.3389/fbioe.2020.00880.</mixed-citation>
     <mixed-citation xml:lang="en">Zhao R.,  Lu Z., Yang J., Zhang L.,  Li Y., Zhang X. Drug Delivery System in the Treatment of Diabetes Mellitus.  Front  BioengBiotechnol.  2020;8:880.  doi: 10.3389/fbioe.2020.00880.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B4">
    <label>4.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L.,  Motala  A.A.,  Ogurtsova  K.,  Shaw  JE,  Bright  D., Williams  R.  Global  and  regional  diabetes  prevalence estimates for 2019 and projections for 2030 and 2045: results  from  the  International  Diabetes  Federation Diabetes  Atlas,  9th  edition.  Diabetes  Res.  Clin.  Pract. 2019;157:107843.  doi:10.1016/j.diabres.2019.107843</mixed-citation>
     <mixed-citation xml:lang="en">Saeedi P., Petersohn I., Salpea P., Malanda B., Karuranga S., Unwin N., Colagiuri S., Guariguata L.,  Motala  A.A.,  Ogurtsova  K.,  Shaw  JE,  Bright  D., Williams  R.  Global  and  regional  diabetes  prevalence estimates for 2019 and projections for 2030 and 2045: results  from  the  International  Diabetes  Federation Diabetes  Atlas,  9th  edition.  Diabetes  Res.  Clin.  Pract. 2019;157:107843.  doi:10.1016/j.diabres.2019.107843</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B5">
    <label>5.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Infante-Garcia  C.,  Garcia-Alloza  M.  Review of the Effect of Natural Compounds and Extracts on Neurodegeneration  in  Animal  Models  of  Diabetes Mellitus. Int J Mol Sci. 2019;20(10):2533. doi:10.3390/ ijms20102533.</mixed-citation>
     <mixed-citation xml:lang="en">Infante-Garcia  C.,  Garcia-Alloza  M.  Review of the Effect of Natural Compounds and Extracts on Neurodegeneration  in  Animal  Models  of  Diabetes Mellitus. Int J Mol Sci. 2019;20(10):2533. doi:10.3390/ ijms20102533.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B6">
    <label>6.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Forouhi N.G., Wareham N.J. Epidemiology of diabetes.  Medicine.  2014;42:698-702.  doi:  10.1016/j. mpmed.2014.09.007.</mixed-citation>
     <mixed-citation xml:lang="en">Forouhi N.G., Wareham N.J. Epidemiology of diabetes.  Medicine.  2014;42:698-702.  doi:  10.1016/j. mpmed.2014.09.007.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B7">
    <label>7.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pati S., van den Akker M., Schellevis F.G., Jena S., Burgers J.S. Impact of comorbidity on health- related quality of life among type 2 diabetic patients in primary care. Prim Health Care Res Dev. 2020;21:e9. doi:10.1017/S1463423620000055</mixed-citation>
     <mixed-citation xml:lang="en">Pati S., van den Akker M., Schellevis F.G., Jena S., Burgers J.S. Impact of comorbidity on health- related quality of life among type 2 diabetic patients in primary care. Prim Health Care Res Dev. 2020;21:e9. doi:10.1017/S1463423620000055</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B8">
    <label>8.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Graves  L.E.,  Donaghue  K.C.  Vascular Complication in  Adolescents With  Diabetes  Mellitus. 2020;11:370. doi: 10.3389/fendo.2020.00370.</mixed-citation>
     <mixed-citation xml:lang="en">Graves  L.E.,  Donaghue  K.C.  Vascular Complication in  Adolescents With  Diabetes  Mellitus. 2020;11:370. doi: 10.3389/fendo.2020.00370.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B9">
    <label>9.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Shukla V., Shakya A.K., Perez-Pinzon M.A., Dave K.R. Cerebral ischemic damage in diabetes: an inflammatory  perspective.  J  Neuroinflammation. 2017;14:21. doi:10.1186/s12974-016-0774-5</mixed-citation>
     <mixed-citation xml:lang="en">Shukla V., Shakya A.K., Perez-Pinzon M.A., Dave K.R. Cerebral ischemic damage in diabetes: an inflammatory  perspective.  J  Neuroinflammation. 2017;14:21. doi:10.1186/s12974-016-0774-5</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B10">
    <label>10.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rozanska  O.,  Uruska  A.,  Zozulinska- Ziolkiewicz D. Brain-Derived Neurotrophic Factor and Diabetes. Int J Mol Sci. 2020;21(3):841. doi: 10.3390/ ijms21030841.</mixed-citation>
     <mixed-citation xml:lang="en">Rozanska  O.,  Uruska  A.,  Zozulinska- Ziolkiewicz D. Brain-Derived Neurotrophic Factor and Diabetes. Int J Mol Sci. 2020;21(3):841. doi: 10.3390/ ijms21030841.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B11">
    <label>11.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Seaquist  E.R.  The  Impact  of  Diabetes on  Cerebral  Structure  and  Function.  Psychosom Me  d  .  2 01 5 ;7 7( 6) :6 16 -21.  do  i:10 .1097 /  PSY.0000000000000207.</mixed-citation>
     <mixed-citation xml:lang="en">Seaquist  E.R.  The  Impact  of  Diabetes on  Cerebral  Structure  and  Function.  Psychosom Me  d  .  2 01 5 ;7 7( 6) :6 16 -21.  do  i:10 .1097 /  PSY.0000000000000207.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B12">
    <label>12.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ferris J.K., Inglis J.T., Madden K.M., Boyd L.A. Brain and Body: A Review of Central Nervous System  Contributions  to  Movement  Impairments  in Diabetes.  Diabetes.  2020;69(1):3-11.  doi:10.2337/db19- 0321.</mixed-citation>
     <mixed-citation xml:lang="en">Ferris J.K., Inglis J.T., Madden K.M., Boyd L.A. Brain and Body: A Review of Central Nervous System  Contributions  to  Movement  Impairments  in Diabetes.  Diabetes.  2020;69(1):3-11.  doi:10.2337/db19- 0321.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B13">
    <label>13.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Peng H., Luo P., Li Y., Wang C., Liu X., Ye Z., Li C., Lou T. Simvastatin alleviates hyperpermeability of  glomerular  endothelial  cells  in  early-stage  diabetic nephropathy by inhibition of RhoA/ROCK1. PLoS One. 2013;8:e80009. doi: 10.1371/journal.pone.0080009.</mixed-citation>
     <mixed-citation xml:lang="en">Peng H., Luo P., Li Y., Wang C., Liu X., Ye Z., Li C., Lou T. Simvastatin alleviates hyperpermeability of  glomerular  endothelial  cells  in  early-stage  diabetic nephropathy by inhibition of RhoA/ROCK1. PLoS One. 2013;8:e80009. doi: 10.1371/journal.pone.0080009.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B14">
    <label>14.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Prasad S.,  Sajja  R.K.,  Naik  P.,  Cucullo L.  Diabetes  Mellitus  and  Blood-Brain  Barrier Dysfunction:  An  Overview.  J  Pharmacovigil. 2014;2:125. doi:10.4172/2329-6887.1000125.</mixed-citation>
     <mixed-citation xml:lang="en">Prasad S.,  Sajja  R.K.,  Naik  P.,  Cucullo L.  Diabetes  Mellitus  and  Blood-Brain  Barrier Dysfunction:  An  Overview.  J  Pharmacovigil. 2014;2:125. doi:10.4172/2329-6887.1000125.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B15">
    <label>15.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Domingueti  C.P.,  Dusse  L.M.,  Carvalho M.,  de  Sousa  L.P.,  Gomes  K.B.,  Fernandes  A.P. Diabetes  mellitus:  The  linkage  between  oxidative stress,  inflammation,  hypercoagulability  and  vascular complications. J. Diabetes Complicat. 2016;30:738-745. doi: 10.1016/j.jdiacomp.2015.12.018.</mixed-citation>
     <mixed-citation xml:lang="en">Domingueti  C.P.,  Dusse  L.M.,  Carvalho M.,  de  Sousa  L.P.,  Gomes  K.B.,  Fernandes  A.P. Diabetes  mellitus:  The  linkage  between  oxidative stress,  inflammation,  hypercoagulability  and  vascular complications. J. Diabetes Complicat. 2016;30:738-745. doi: 10.1016/j.jdiacomp.2015.12.018.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B16">
    <label>16.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rehni  A.K.,  Dave  K.R.  Impact  of Hypoglycemia on Brain Metabolism During Diabetes. MolNeurobiol.  2018;55(12):9075-9088.  doi:10.1007/ s12035-018-1044-6.</mixed-citation>
     <mixed-citation xml:lang="en">Rehni  A.K.,  Dave  K.R.  Impact  of Hypoglycemia on Brain Metabolism During Diabetes. MolNeurobiol.  2018;55(12):9075-9088.  doi:10.1007/ s12035-018-1044-6.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B17">
    <label>17.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pugazhenthi S., Qin L., Reddy P.H. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis 2017;1863(5):1037-1045. doi:10.1016/j. bbadis.2016.04.017.</mixed-citation>
     <mixed-citation xml:lang="en">Pugazhenthi S., Qin L., Reddy P.H. Common neurodegenerative pathways in obesity, diabetes, and Alzheimer’s disease. Biochim Biophys Acta Mol Basis Dis 2017;1863(5):1037-1045. doi:10.1016/j. bbadis.2016.04.017.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B18">
    <label>18.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Fendler  W.,  Borowiec  M.,  Baranowska- Jazwiecka A., Szadkowska A., Skala-Zamorowska E., Deja G., Jarosz-Chobot P., Techmanska I., Bautembach- Minkowska  J.,  Mysliwiec  M.,  Zmyslowska  A., Pietrzak I., Malecki M.T., Mlynarski W. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia. 2012;55(10):2631-2635.  doi:  10.1007/s00125-012- 2621-2.</mixed-citation>
     <mixed-citation xml:lang="en">Fendler  W.,  Borowiec  M.,  Baranowska- Jazwiecka A., Szadkowska A., Skala-Zamorowska E., Deja G., Jarosz-Chobot P., Techmanska I., Bautembach- Minkowska  J.,  Mysliwiec  M.,  Zmyslowska  A., Pietrzak I., Malecki M.T., Mlynarski W. Prevalence of monogenic diabetes amongst Polish children after a nationwide genetic screening campaign. Diabetologia. 2012;55(10):2631-2635.  doi:  10.1007/s00125-012- 2621-2.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B19">
    <label>19.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Temneanu O.R., Trandafir L.M., Purcarea MR. Type 2 diabetes mellitus in children and adolescents: a  relatively  new  clinical  problem  within  pediatric practice. J Med Life. 2016;9(3):235-239.</mixed-citation>
     <mixed-citation xml:lang="en">Temneanu O.R., Trandafir L.M., Purcarea MR. Type 2 diabetes mellitus in children and adolescents: a  relatively  new  clinical  problem  within  pediatric practice. J Med Life. 2016;9(3):235-239.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B20">
    <label>20.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Santi E., Tascini G., Toni G., Berioli M.G., Esposito S. Linear Growth in Children and Adolescents with Type 1 Diabetes Mellitus.  Int J Environ Res Public Health. 2019;16(19):3677. doi: 10.3390/ijerph16193677.</mixed-citation>
     <mixed-citation xml:lang="en">Santi E., Tascini G., Toni G., Berioli M.G., Esposito S. Linear Growth in Children and Adolescents with Type 1 Diabetes Mellitus.  Int J Environ Res Public Health. 2019;16(19):3677. doi: 10.3390/ijerph16193677.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B21">
    <label>21.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Rapini  N.,  Schiaffini  R.,  Fierabracci  A. Immunotherapy  Strategies  for  the  Prevention  and Treatment of Distinct Stages of Type 1 Diabetes: An Overview. Int J Mol Sci. 2020;21(6):2103. doi: 10.3390/ ijms21062103.</mixed-citation>
     <mixed-citation xml:lang="en">Rapini  N.,  Schiaffini  R.,  Fierabracci  A. Immunotherapy  Strategies  for  the  Prevention  and Treatment of Distinct Stages of Type 1 Diabetes: An Overview. Int J Mol Sci. 2020;21(6):2103. doi: 10.3390/ ijms21062103.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B22">
    <label>22.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Батурин В.А., Быков Ю.В., Мамцева Г.И., Углова Т.А. Сравнительный анализ уровня анти- тел к инсулиновым рецепторам у детей с сахарным диабетом I типа в зависимости от стадии заболевания.  Медицинский  Вестник  Северного  Кавказа. 2016;11:(1);80-82. doi:10.14300/mnnc.2016.11003</mixed-citation>
     <mixed-citation xml:lang="en">Baturin V.A., Bykov Yu.V., Mamceva G.I., Uglova T.A. Sravnitel'nyy analiz urovnya anti- tel k insulinovym receptoram u detey s saharnym diabetom I tipa v zavisimosti ot stadii zabolevaniya.  Medicinskiy  Vestnik  Severnogo  Kavkaza. 2016;11:(1);80-82. doi:10.14300/mnnc.2016.11003</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B23">
    <label>23.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Быков  Ю.В.,  Батурин  В.А.,  Углова  Т.А. Оценка  уровней  аутоантител  к  NMDA  и  дофа- миновым рецепторам у детей больных сахарным диабетом  I  типа  в  зависимости  от  тяжести  течения  заболевания.  Медицина  2020;8(2):73-80. doi:10.29234/2308-9113-2020-8-2-73-80</mixed-citation>
     <mixed-citation xml:lang="en">Bykov  Yu.V.,  Baturin  V.A.,  Uglova  T.A. Ocenka  urovney  autoantitel  k  NMDA  i  dofa- minovym receptoram u detey bol'nyh saharnym diabetom  I  tipa  v  zavisimosti  ot  tyazhesti  techeniya  zabolevaniya.  Medicina  2020;8(2):73-80. doi:10.29234/2308-9113-2020-8-2-73-80</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B24">
    <label>24.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Engin F. ER stress and development of type 1 diabetes. J Investig Med. 2016;64(1):2-6. doi: 10.1097/ JIM.0000000000000229.</mixed-citation>
     <mixed-citation xml:lang="en">Engin F. ER stress and development of type 1 diabetes. J Investig Med. 2016;64(1):2-6. doi: 10.1097/ JIM.0000000000000229.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B25">
    <label>25.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Szmygel L., Kosiak W., Zorena K., Myśliwiec M. Optic Nerve and Cerebral Edema in the Course of Diabetic  Ketoacidosis.  CurrNeuropharmacol. 2016;14(8):784-791.  doi:  10.2174/1570159x146661602 25155151.</mixed-citation>
     <mixed-citation xml:lang="en">Szmygel L., Kosiak W., Zorena K., Myśliwiec M. Optic Nerve and Cerebral Edema in the Course of Diabetic  Ketoacidosis.  CurrNeuropharmacol. 2016;14(8):784-791.  doi:  10.2174/1570159x146661602 25155151.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B26">
    <label>26.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Wolfsdorf J.I., Allgrove J., Craig M.E., Edge J., Glaser N., Jain V., Lee W.W., Mungai L.N., Rosenbloom A.L., Sperling M.A., Hanas R.A. Chapter 11: Diabetic ketoacidosis and hyper- glycemic hypersmolar state ISPAD  Clinical  Practice  Consensus  Guidelines 2014. Pediatr. Diabetes. 2014;15(Suppl. 20):154-179. doi:10.1111/pedi.12165.</mixed-citation>
     <mixed-citation xml:lang="en">Wolfsdorf J.I., Allgrove J., Craig M.E., Edge J., Glaser N., Jain V., Lee W.W., Mungai L.N., Rosenbloom A.L., Sperling M.A., Hanas R.A. Chapter 11: Diabetic ketoacidosis and hyper- glycemic hypersmolar state ISPAD  Clinical  Practice  Consensus  Guidelines 2014. Pediatr. Diabetes. 2014;15(Suppl. 20):154-179. doi:10.1111/pedi.12165.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B27">
    <label>27.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Assefa  B.,  Zeleke  H.,  Murugan  R., Wondwossen K. Incidence and predictors of diabetic ketoacidosis among children with diabetes in west and east Gojjam zone referral hospitals, northern Ethiopia, 2019.  Ital  J  Pediatr.  2020;46(1):164.  doi:10.1186/ s13052-020-00930-4.</mixed-citation>
     <mixed-citation xml:lang="en">Assefa  B.,  Zeleke  H.,  Murugan  R., Wondwossen K. Incidence and predictors of diabetic ketoacidosis among children with diabetes in west and east Gojjam zone referral hospitals, northern Ethiopia, 2019.  Ital  J  Pediatr.  2020;46(1):164.  doi:10.1186/ s13052-020-00930-4.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B28">
    <label>28.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pourabbasi  A.,  Tehrani-Doost  M.,  Qavam S.E., Arzaghi S.M., Larijani B. Association of diabetes mellitus and structural changes in the central nervous system in children and adolescents: a systematic review. J   Diabetes  MetabDisord.  2017;16:10.  doi:  10.1186/ s40200-017-0292-8.</mixed-citation>
     <mixed-citation xml:lang="en">Pourabbasi  A.,  Tehrani-Doost  M.,  Qavam S.E., Arzaghi S.M., Larijani B. Association of diabetes mellitus and structural changes in the central nervous system in children and adolescents: a systematic review. J   Diabetes  MetabDisord.  2017;16:10.  doi:  10.1186/ s40200-017-0292-8.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B29">
    <label>29.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Pourabbasi A ., Tehrani-Doost M., Qavam S.E., Larijani B. Evaluation of the correlation between type  1  diabetes  and  cognitive  function  in  children and adolescents, and comparison of this correlation with structural changes in the central nervous system: a  study  protocol.  BMJ  Open.  2016;6(4):e007917. doi:10.1136/bmjopen-2015-007917.</mixed-citation>
     <mixed-citation xml:lang="en">Pourabbasi A ., Tehrani-Doost M., Qavam S.E., Larijani B. Evaluation of the correlation between type  1  diabetes  and  cognitive  function  in  children and adolescents, and comparison of this correlation with structural changes in the central nervous system: a  study  protocol.  BMJ  Open.  2016;6(4):e007917. doi:10.1136/bmjopen-2015-007917.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B30">
    <label>30.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Ryan C.M., van Duinkerken E., Rosano C. Neurocognitive consequences of diabetes. Am Psychol. 2016;71(7):563-576. doi:10.1037/a0040455.</mixed-citation>
     <mixed-citation xml:lang="en">Ryan C.M., van Duinkerken E., Rosano C. Neurocognitive consequences of diabetes. Am Psychol. 2016;71(7):563-576. doi:10.1037/a0040455.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B31">
    <label>31.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Semenkovich K., Bischoff A., Doty T., Nelson S.,  Siller  A.F.,  Hershey  T.,  Arbelбez  A.M.  Clinical presentation  and  memory  function  in  youth  with type  1  diabetes.  Pediatr  Diabetes  2016;17:492-499. doi:10.1111/pedi.12314.</mixed-citation>
     <mixed-citation xml:lang="en">Semenkovich K., Bischoff A., Doty T., Nelson S.,  Siller  A.F.,  Hershey  T.,  Arbelbez  A.M.  Clinical presentation  and  memory  function  in  youth  with type  1  diabetes.  Pediatr  Diabetes  2016;17:492-499. doi:10.1111/pedi.12314.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B32">
    <label>32.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Aye T., Mazaika P.K., Mauras N., Marzelli M.J., Shen H., Hershey T., Cato A., Weinzimer S.A., White N.H., Tsalikian E., Jo B., Reiss A. Impact of Early Diabetic Ketoacidosis on the Developing Brain. Diabetes Care. 2019;42(3):443-449. doi:10.2337/dc18- 1405.</mixed-citation>
     <mixed-citation xml:lang="en">Aye T., Mazaika P.K., Mauras N., Marzelli M.J., Shen H., Hershey T., Cato A., Weinzimer S.A., White N.H., Tsalikian E., Jo B., Reiss A. Impact of Early Diabetic Ketoacidosis on the Developing Brain. Diabetes Care. 2019;42(3):443-449. doi:10.2337/dc18- 1405.</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B33">
    <label>33.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Biessels  G.J.,  Despa  F.  Cognitive  decline and dementia in diabetes: mechanisms and clinical implications.  Nat  Rev  Endocrinol.  2018;14(10):591- 604. doi:10.1038/s41574-018-0048-7</mixed-citation>
     <mixed-citation xml:lang="en">Biessels  G.J.,  Despa  F.  Cognitive  decline and dementia in diabetes: mechanisms and clinical implications.  Nat  Rev  Endocrinol.  2018;14(10):591- 604. doi:10.1038/s41574-018-0048-7</mixed-citation>
    </citation-alternatives>
   </ref>
   <ref id="B34">
    <label>34.</label>
    <citation-alternatives>
     <mixed-citation xml:lang="ru">Qian J., Scheer FA. Circadian System and Glucose Metabolism: Implications for Physiology and Disease. Trends EndocrinolMetab. 2016;27(5):282-293. doi: 10.1016/j.tem.2016.03.005</mixed-citation>
     <mixed-citation xml:lang="en">Qian J., Scheer FA. Circadian System and Glucose Metabolism: Implications for Physiology and Disease. Trends EndocrinolMetab. 2016;27(5):282-293. doi: 10.1016/j.tem.2016.03.005</mixed-citation>
    </citation-alternatives>
   </ref>
  </ref-list>
 </back>
</article>
